Vaxcyte Inc (NASDAQ:PCVX) shares, rose in value on Wednesday, April 16, with the stock price down by -3.67% to the previous day’s close as strong demand from buyers drove the stock to $29.12.
Actively observing the price movement in the last trading, the stock closed the session at $30.23, falling within a range of $28.58 and $30.39. The value of beta (5-year monthly) was 1.264. Referring to stock’s 52-week performance, its high was $121.06, and the low was $27.66. On the whole, PCVX has fluctuated by -61.03% over the past month.
With the market capitalization of Vaxcyte Inc currently standing at about $3.75 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-24.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PCVX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PCVX currently trading nearly -36.25% and -55.42% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 23.45, while the 7-day volatility ratio is showing 9.11% which for the 30-day chart, stands at 9.79%. Furthermore, Vaxcyte Inc (PCVX)’s beta value is 1.32, and its average true range (ATR) is 4.46.
A comparison of Vaxcyte Inc (PCVX) with its peers suggests the former has fared considerably weaker in the market. PCVX showed an intraday change of -3.67% in last session, and over the past year, it shrunk by -53.33%%.
Data on historical trading for Vaxcyte Inc (NASDAQ:PCVX) indicates that the trading volumes over the past 10 days have averaged 3.9 and over the past 3 months, they’ve averaged 1.97 million. According to company’s latest data on outstanding shares, there are 128.76 million shares outstanding.
Nearly 2.89% of Vaxcyte Inc’s shares belong to company insiders and institutional investors own 108.16% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 12.05 million shares as on 2025-03-31, resulting in a short ratio of 6.85. According to the data, the short interest in Vaxcyte Inc (PCVX) stood at 1057.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 12.33 million. The stock has fallen by -64.43% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PCVX stock heading into the next quarter.
